We recently reported that the regulation of post-ischemic glucose intolerance by intrahypothalamic administration of orexin-A: (1) restored (to sham levels) the decrease of InsR and the increase of gluconeogenic enzymes in the liver, and (2) significantly suppressed cerebral ischemic neuronal damage [8]. The gene discussed is INSR; the disease is Glucose intolerance.